Cargando…

Low dose irradiation increases adoptive cytotoxic T lymphocyte migration in gastric cancer

Adoptive cellular immunotherapy (ACI) has been demonstrated to be a promising cancer therapeutic; however, the inefficient migration of adoptive immune cells to tumors is one of the rate-limiting factors of ACI. The present study investigated whether 2 Gy low dose irradiation (LDI) was able to incre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Juan, Su, Shu, Li, Hongyan, Shao, Jie, Meng, Fanyan, Yang, Mi, Qian, Hanqing, Zou, Zhengyun, Qian, Xiaoping, Liu, Baorui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740708/ https://www.ncbi.nlm.nih.gov/pubmed/29285113 http://dx.doi.org/10.3892/etm.2017.5305

Ejemplares similares

Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer
por: Zhang, Lianru, et al.
Publicado: (2017)

Disappearance of bone metastases in chemotherapy-resistant gastric cancer treated with antigen peptide-pulsed dendritic cell-activated cytotoxic T lymphocyte immunotherapy: A case report
por: Du, Juan, et al.
Publicado: (2018)

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer
por: Ding, Naiqing, et al.
Publicado: (2019)

CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells for adoptive therapy
por: Su, Shu, et al.
Publicado: (2015)

Superior Antitumor Efficacy of IFN-α2b-Incorporated Photo-Cross-Linked Hydrogels Combined with T Cell Transfer and Low-Dose Irradiation Against Gastric Cancer
por: Liu, Qin, et al.
Publicado: (2020)

Gastric metastasis from sphenoid sinus melanoma: A case report
por: ZHAO, LIANJUN, et al.
Publicado: (2015)

Gambogic acid regulates the migration and invasion of colorectal cancer via microRNA-21-mediated activation of phosphatase and tensin homolog
por: Gao, Guangyi, et al.
Publicado: (2018)

Synergistic Anticancer Effects of Polyphyllin I and Evodiamine on Freshly-Removed Human Gastric Tumors
por: Yue, Guofeng, et al.
Publicado: (2013)

The plasma levels of 12 cytokines and growth factors in patients with gastric cancer
por: Zou, Zhengyun, et al.
Publicado: (2018)

A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer
por: Shen, Jie, et al.
Publicado: (2013)

Adoptive tumor infiltrating lymphocytes cell therapy for cervical cancer
por: Zhu, Yahui, et al.
Publicado: (2022)

Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell lines
por: Zou, Zhengyun, et al.
Publicado: (2012)

Plasma mRNA expression levels of BRCA1 and TS as potential predictive biomarkers for chemotherapy in gastric cancer
por: Shen, Jie, et al.
Publicado: (2014)

Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment
por: Zhang, Zhen, et al.
Publicado: (2017)

Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation
por: Zhou, Shujuan, et al.
Publicado: (2021)

The Herb Medicine Formula “Chong Lou Fu Fang” Increases the Cytotoxicity of Chemotherapeutic Agents and Down-Regulates the Expression of Chemotherapeutic Agent Resistance-Related Genes in Human Gastric Cancer Cells In Vitro
por: Liu, Yongping, et al.
Publicado: (2011)

Modification of erythrocytes by internalizing Arg-Gly-Asp (iRGD) in boosting the curative effect of radiotherapy for gastric carcinoma
por: Zhou, Chong, et al.
Publicado: (2022)

SULF2 Methylation Is Associated with In Vitro Cisplatin Sensitivity and Clinical Efficacy for Gastric Cancer Patients Treated with a Modified FOLFOX Regimen
por: Shen, Jie, et al.
Publicado: (2013)

Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer
por: Zhang, Dinghu, et al.
Publicado: (2020)

Tumor vessel-injuring ability improves antitumor effect of cytotoxic T lymphocytes in adoptive immunotherapy
por: Kanagawa, N, et al.
Publicado: (2013)

CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients
por: Su, Shu, et al.
Publicado: (2016)

Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients
por: Su, Shu, et al.
Publicado: (2017)

Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment
por: Zhang, Zhen, et al.
Publicado: (2018)

Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein
por: Chen, Hong, et al.
Publicado: (2018)

Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric Cancer
por: Yang, Ju, et al.
Publicado: (2019)

Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer
por: Qiu, Xin, et al.
Publicado: (2023)

CELL INTERACTIONS BETWEEN HISTOINCOMPATIBLE T AND B LYMPHOCYTES : I. ALLOGENEIC EFFECT BY IRRADIATED HOST T CELLS ON ADOPTIVELY TRANSFERRED HISTOINCOMPATIBLE B LYMPHOCYTES
por: Hamaoka, Toshiyuki, et al.
Publicado: (1973)

Enhancement of Radiation Effects by Ursolic Acid in BGC-823 Human Adenocarcinoma Gastric Cancer Cell Line
por: Yang, Yang, et al.
Publicado: (2015)

Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy
Publicado: (1991)

Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury
por: Asai, Hiroaki, et al.
Publicado: (2014)

Use of Pulsed Low–Dose Rate Radiotherapy in Refractory Malignancies()()
por: Yan, Jing, et al.
Publicado: (2018)

Metabolic radiolabeling and in vivo PET imaging of cytotoxic T lymphocytes to guide combination adoptive cell transfer cancer therapy
por: Lu, Dehua, et al.
Publicado: (2021)

Tumor eradicated by combination of imiquimod and OX40 agonist for in situ vaccination
por: Chu, Yanhong, et al.
Publicado: (2021)

In situ gelatinase-responsive and thermosensitive nanocomplex for local therapy of gastric cancer with peritoneal metastasis
por: Wang, Xinyue, et al.
Publicado: (2022)

Specificity Characterization of SLA Class I Molecules Binding to Swine-Origin Viral Cytotoxic T Lymphocyte Epitope Peptides in Vitro
por: Gao, Caixia, et al.
Publicado: (2017)

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
por: Andersen, Rikke, et al.
Publicado: (2014)

Adoptive T-cell transfer combined with a single low dose of total body irradiation eradicates breast tumors
por: Lerret, Nadine M., et al.
Publicado: (2013)

Benefits of an Immunogenic Personalized Neoantigen Nanovaccine in Patients with High‐Risk Gastric/Gastroesophageal Junction Cancer
por: Liu, Qin, et al.
Publicado: (2022)

Anti-EGFR-iRGD recombinant protein conjugated silk fibroin nanoparticles for enhanced tumor targeting and antitumor efficiency
por: Bian, Xinyu, et al.
Publicado: (2016)

Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy
por: Nguyen, Linh T, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_op8sm5kearm7cqfdi1aaapi208